extrinsic allergic alveolitis: An inflammatory interstitial lung disease caused by hypersensitivity reaction to inhalation or ingestion of antigens. The antigens are usually related to the patient's occupation. It can present as an acute illness with flu-like symptoms, subacute with repeated episodes of pneumonia, or chronic with dyspnea and productive cough. The majority of patients recover following the cessation of the exposure to the antigen that causes the disease. Chronic exposure may eventually progress to interstitial lung fibrosis.
Hypersensitivity pneumonitis due to organic dust
DOID EFO Endpoint Browser PheWeb
J10_HYPERSPNEUMONI
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
582 |
4. Check minimum number of eventsNone |
582 |
5. Include endpointsNone |
582 |
6. Filter based on genotype QC (FinnGen only) |
582 |
Control definitions (FinnGen only)
- Control exclude
- J10_EXTERLUNG
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J60-J70
- Name in latin
- Pneumonitis/alveolitis hypersensitiva e pulvere organico
Similar endpoints
↥List of similar endpoints to
Hypersensitivity pneumonitis due to organic dust
based on the number of shared cases.
Similar with more cases:
- Lung diseases due to external agents
- Diagnoses used for exclusion with ILD
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5824 | 2873 | 2887 |
| Only index persons | 4602 | 2341 | 2261 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.08 |
| Only index persons | 0.09 | 0.09 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 52.93 | 53.15 | 52.37 |
| Only index persons | 49.96 | 50.96 | 48.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 582 | 301 | 281 |
| Unadjusted period prevalence (%) | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | 49.81 | 47.62 | 52.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 533
- Matched controls
- 5329
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J67.0
ICD-10 Finland
Farmer lung
+∞
192.7
173
*
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
+∞
170.2
154
*
4950A
ICD-9 Finland
Extrinsic allergic alveolitis, Farmers' lung
+∞
114.8
106
*
4959X
ICD-9 Finland
Extrinsic allergic alveolitis, Unspecified allergic alveolitis and pneumonitis
+∞
90.2
84
*
H02AB06
ATC
prednisolone; systemic
3.6
43.3
343
1772
TGC00
NOMESCO Finland
Bronchial lavation
13.3
42.3
76
66
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
+∞
40.1
38
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.5
33.6
108
235
J45.9
ICD-10 Finland
Asthma, unspecified
3.6
29.1
155
543
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.3
28.1
60
72
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
13.1
26.0
46
38
51610
ICD-8 Finland
Other pneumoconiosis and related diseases, Due to inhalation of other dust
+∞
25.2
24
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.5
25.2
68
117
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.3
25.0
102
280
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
11.6
24.1
45
42
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.5
22.9
71
145
J45.1
ICD-10 Finland
Nonallergic asthma
4.6
21.5
80
199
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.9
21.4
153
644
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
52.3
21.3
25
5
R03AC02
ATC
salbutamol; inhalant
2.2
17.7
309
2036
R06.0
ICD-10 Finland
Dyspnoea
2.5
17.7
175
874
XG410
NOMESCO Finland
Flow-volume spirometry
5.1
16.7
54
116
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.4
16.6
44
74
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.5
16.1
79
251
1240
FHL
Bronchoscopy
15.1
16.0
26
18
J01FA06
ATC
roxithromycin; oral
2.2
16.0
248
1523
4958X
ICD-9 Finland
Extrinsic allergic alveolitis, Other specified allergic alveolitis and pneumonitis
+∞
15.7
15
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
11.3
15.2
28
26
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
15.0
163
841
R03BA01
ATC
beclometasone; inhalant
2.7
14.6
107
446
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
11.4
13.1
24
22
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.7
13.1
99
420
J67.2
ICD-10 Finland
Bird fancier lung
+∞
12.5
12
*
J67.1
ICD-10 Finland
Bagassosis
+∞
12.5
12
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
13.8
12.0
20
15
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
19.5
11.7
17
9
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
23.5
11.6
16
7
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
9.9
11.3
22
23
J47
ICD-10 Finland
Bronchiectasis
7.9
11.3
25
33
J66.8
ICD-10 Finland
Airway disease due to other specific organic dusts
+∞
10.4
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
10.1
65
247
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
12.5
9.9
17
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
9.7
248
1732
L04AX01
ATC
azathioprine; systemic
4.0
9.7
38
100
R03BA02
ATC
budesonide; inhalant
2.2
9.6
110
570
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
5.4
9.3
27
52
R03AC12
ATC
salmeterol; inhalant
3.5
9.3
42
126
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.8
9.2
61
238
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
12.8
8.9
15
12
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
14.3
8.7
14
10
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
8.5
37
108
Z94.2
ICD-10 Finland
Lung transplant status
91.5
8.4
9
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.9
8.1
32
86
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
8.0
45
158
R50.9
ICD-10 Finland
Fever, unspecified
2.2
7.9
84
420
GDA10
NOMESCO Finland
Biopsy of lung
45.7
7.7
9
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.3
120
708
J67.7
ICD-10 Finland
Air-conditioner and humidifier lung
+∞
7.3
7
*
51620
ICD-8 Finland
Other pneumoconiosis and related diseases, Due to inhalation of fumes
+∞
7.3
7
*
R03BB04
ATC
tiotropium bromide; inhalant
2.3
7.1
68
322
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
7.0
36
120
R03AC03
ATC
terbutaline; inhalant
2.1
7.0
82
425
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
5.8
6.8
18
32
R03DA04
ATC
theophylline; systemic, rectal
3.0
6.7
36
124
J45.8
ICD-10 Finland
Mixed asthma
3.5
6.6
29
86
GDG10
NOMESCO Finland
Bilateral transplantation of lung
70.7
6.4
7
*
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
10.2
6.1
11
11
J01MA14
ATC
moxifloxacin; systemic
2.2
6.0
59
284
R05
ICD-10 Finland
Cough
1.8
6.0
100
593
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
49
50
10.61
43.30
2.4
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
87
175
5.67
42.32
3.3
2.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
96
273
4.01
30.17
1.8
1.2
u/ml
145.2
152.9
0.05
85
242
(3023419) Bacteria identified in Sputum by Culture
44
68
6.92
27.65
5.2
2.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
33
38
9.15
26.52
1.5
1.2
u/ml
0.1
0.1
0.24
20
18
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
89
5.79
25.19
2.4
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
99
326
3.45
24.85
4.7
4.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
29
9
33.81
22.61
1.4
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
70
5.90
21.13
2.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
117
4.68
21.02
2.5
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
23
22
10.84
21.01
2.5
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
129
550
2.73
20.38
6.2
7.9
mmol/l
1.1
1.2
0.16
104
438
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
129
554
2.71
20.07
6.2
7.8
kpa
5.0
5.1
0.35
123
531
(3027801) Oxygen [Partial pressure] in Arterial blood
129
555
2.70
19.99
6.2
7.8
kpa
10.3
12.2
4.67
124
532
(3016502) Oxygen saturation in Arterial blood
120
500
2.76
19.77
6.3
8.2
%
93.5
95.6
2.20
114
484
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
50
121
4.43
19.27
2.5
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
35
71
5.18
16.61
3.1
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
46
118
4.15
16.42
2.6
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
82
315
2.87
15.57
6.7
7.1
mmol/l
24.9
24.5
0.46
77
296
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
24
8.59
15.46
1.9
2.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
53
159
3.57
15.16
1.8
1.6
titre
700.0
163.3
—
6
6
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
26
7.93
14.50
1.8
2.0
%
17.2
14.8
0.20
12
14
(44790048)
30
60
5.22
14.46
2.6
1.7
—
—
—
0
0
(44806118)
30
60
5.22
14.46
2.6
1.7
—
—
—
0
0
(44790049)
30
60
5.22
14.46
2.6
1.7
—
—
—
0
0
(44790047)
30
60
5.22
14.46
2.6
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
86
4.40
14.08
2.7
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
54
5.40
14.04
3.1
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
37
91
4.27
13.94
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
180
1033
2.07
13.80
6.9
4.6
—
—
—
0
0
(4062490)
23
39
6.10
13.15
1.1
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
328
2341
1.92
13.14
9.2
5.7
e9/l
0.6
0.6
1.51
303
2028
(3006315) Basophils [#/volume] in Blood
328
2353
1.90
12.81
9.3
5.7
e9/l
0.0
0.0
0.28
303
2047
(3019198) Lymphocytes [#/volume] in Blood
332
2393
1.90
12.75
9.3
5.8
e9/l
1.8
1.9
1.02
308
2119
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
37
6.14
12.68
1.1
1.4
g/l
8.4
7.1
0.64
15
27
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
37
6.14
12.68
1.1
1.4
g/l
0.5
0.4
0.54
15
27
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
37
6.14
12.68
1.1
1.4
g/l
3.2
2.7
0.46
16
27
(3013115) Eosinophils [#/volume] in Blood
334
2437
1.87
12.09
10.0
6.0
e9/l
0.2
0.2
0.98
310
2151
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
70
4.46
12.08
1.9
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
88
396
2.44
12.07
5.2
4.3
%
1.0
0.9
0.01
26
138
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
79
4.23
12.00
1.9
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
85
382
2.43
11.68
4.3
2.8
g/l
11.4
10.5
0.52
80
351
(3021440) Promyelocytes/100 leukocytes in Blood
82
366
2.44
11.43
5.2
4.5
%
0.0
0.1
0.81
25
122
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
35
97
3.78
11.23
1.6
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
11
11.12
11.09
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
29
71
4.25
10.99
2.9
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
79
356
2.41
10.77
4.8
4.4
%
0.9
0.5
0.49
17
101
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
41
5.28
10.38
1.4
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
28
70
4.15
10.34
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
10
11.19
10.19
5.8
3.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
76
346
2.38
10.11
5.0
4.6
%
0.0
1.0
0.62
21
107
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
218
1463
1.78
9.78
3.7
3.2
ng/l
1195.3
1423.2
0.39
198
1251
(3022096) Basophils/100 leukocytes in Blood
293
2143
1.74
9.70
9.7
5.9
%
0.6
0.7
2.29
287
1999
(3019069) Monocytes/100 leukocytes in Blood
300
2217
1.73
9.50
10.4
6.1
%
8.5
8.7
0.77
293
2083
(3013650) Neutrophils [#/volume] in Blood by Automated count
354
2740
1.75
9.48
13.3
9.2
e9/l
4.5
4.1
2.02
332
2410
(3006504) Eosinophils/100 leukocytes in Blood
298
2206
1.72
9.31
9.9
5.9
%
2.5
2.9
2.55
290
2058
(4010399)
73
340
2.31
9.21
2.0
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32
96
3.47
9.16
20.3
7.2
iu/ml
268.3
209.5
0.18
14
16
(3037522) Nuclear Ab [Titer] in Serum
113
626
2.00
9.15
1.6
1.3
titre
604.6
490.5
0.23
35
126
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
40
140
2.99
8.93
2.2
2.2
mg/l
10.7
12.2
0.48
40
130
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
18
7.36
8.88
4.8
5.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
297
2221
1.69
8.75
9.7
5.8
%
60.4
57.5
4.74
290
2088
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
16
29
5.64
8.54
2.1
2.0
e9/l
0.2
0.2
0.01
16
24
(42870588) Differential panel, method unspecified - Blood
225
1572
1.70
8.48
9.8
5.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
299
2262
1.66
8.25
10.2
6.0
%
24.9
27.4
4.34
292
2109
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
61
280
2.32
7.95
7.6
3.9
mmol/l
2.3
1.7
0.60
48
220
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
56
4.04
7.95
1.6
2.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
70
3.69
7.93
1.2
1.7
g/l
0.6
0.8
0.35
19
57
(3029937) Albumin [Presence] in Urine by Test strip
186
1258
1.70
7.77
5.4
3.9
estimate
0.0
0.0
0.69
54
419
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
39
147
2.77
7.64
1.8
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
132
815
1.80
7.57
1.4
1.3
iu/ml
31.8
37.7
0.26
42
271
(3004616) Nuclear Ab [Presence] in Serum
20
50
4.11
7.40
1.4
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
30
5.11
7.22
2.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
158
1040
1.71
7.22
5.6
4.0
kg/l
1.0
1.0
0.17
19
140
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
48
4.06
6.94
1.2
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
12
20
6.11
6.93
3.7
1.8
ug/l
32.0
58.2
1.80
12
20
(3026389) Candida sp identified in Specimen by Organism specific culture
20
53
3.87
6.86
1.2
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
53
3.87
6.86
1.7
2.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
133
2.74
6.77
1.7
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
61
300
2.15
6.74
7.8
3.7
ph
7.4
7.4
—
9
32
(3000494) Fungus identified in Specimen by Culture
100
587
1.85
6.71
2.9
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
128
812
1.74
6.62
2.7
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
116
722
1.76
6.40
2.5
2.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
151
1011
1.67
6.38
3.6
2.5
e6/l
5.6
5.7
0.05
139
894
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
15
6.77
6.33
3.9
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
189
1355
1.58
6.00
5.0
4.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
27
4.90
6.00
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
25
85
3.03
5.91
5.3
2.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
33
131
2.61
5.89
5.4
2.4
mmol/l
25.5
25.0
0.29
33
111
(3013707) Erythrocyte sedimentation rate by Westergren method
413
3532
1.58
5.83
7.1
4.1
mm/h
13.8
12.5
0.91
392
3241
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
9
11.28
5.81
4.4
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
236
1799
1.52
5.62
5.2
3.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
35
149
2.44
5.43
7.0
6.2
mmol/l
1.3
1.2
0.26
30
135
(3008536) Aspergillus sp Ab [Presence] in Serum
10
18
5.64
5.34
1.2
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
8
11.40
5.30
3.2
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
68
380
1.89
5.30
2.7
2.7
ml/min/173m2
66.7
63.8
0.25
33
159
(3009542) Hematocrit [Volume Fraction] of Blood
380
4310
0.66
5.18
23.4
15.7
%
38.1
40.0
1.97
234
3043
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
201
1505
1.51
5.10
3.0
2.4
u/l
60.0
55.9
0.41
191
1406
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
297
2409
1.48
5.05
8.8
6.8
mmol/l
1.2
1.2
0.28
261
2045
(1616796) Gas panel - Central venous blood
25
94
2.73
4.97
8.6
3.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
27
107
2.60
4.86
8.7
2.6
kpa
8.0
8.0
0.04
27
97
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
24
4.65
4.80
2.8
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
29
120
2.49
4.79
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
85
2.78
4.73
1.5
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
43
3.55
4.64
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
44
222
2.06
4.59
8.5
3.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
25
4.47
4.58
2.8
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
573
1.68
4.52
2.8
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
273
2212
1.44
4.49
7.9
5.9
mmol/l
1.2
1.2
0.95
261
2005
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
88
2.68
4.45
1.7
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
50
268
1.95
4.42
3.4
2.7
e6/l
0.2
0.2
0.03
50
260
(3020891) Body temperature
39
192
2.11
4.35
5.7
4.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
89
572
1.66
4.31
2.7
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
108
2.47
4.28
1.2
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
12
31
3.93
4.27
1.4
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
192
1469
1.46
4.23
4.5
3.1
e6/l
137.5
103.9
0.13
165
1126
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
36
3.67
4.22
2.5
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
258
1.94
4.22
11.3
10.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
46
3.32
4.21
2.5
2.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
223
1758
1.44
4.18
4.8
3.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.18
1.4
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
9
13
7.01
4.17
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
13
7.01
4.17
1.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
21
80
2.69
4.10
1.6
1.4
u/ml
106.9
100.4
—
8
16
(3004809) Band form neutrophils/100 leukocytes in Blood
21
80
2.69
4.10
3.6
4.0
%
0.6
1.7
1.01
16
65
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
303
2529
1.41
4.09
8.8
6.4
umol/l
12.2
11.3
0.24
292
2404
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
237
1896
1.42
4.07
4.1
3.7
ng/l
35.8
44.8
0.49
168
1354
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
81
2.65
4.01
1.5
1.2
u/ml
314.9
281.9
0.16
14
45
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
112
774
1.55
4.01
1.4
1.3
u/ml
12.9
13.0
0.01
51
298
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
94
2.51
3.93
3.0
2.1
g/l
140.2
128.5
0.82
17
71
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
59
2.94
3.93
4.7
4.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
141
1031
1.49
3.87
1.7
1.7
pmol/l
447.5
6778084.0
0.50
126
841
(21494814) CD8 cells/100 lymphocytes in Specimen
8
11
7.36
3.87
2.0
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
67
411
1.71
3.86
4.1
3.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
125
894
1.51
3.82
1.9
1.5
g/l
2.5
2.5
0.01
90
555
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
8
8.84
3.78
2.0
2.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
103
2.39
3.71
4.5
4.0
mg/l
14.6
31.2
3.02
19
64
(3000492) Spirometry study
73
465
1.65
3.66
2.3
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
57
2.86
3.55
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
51
298
1.78
3.49
1.6
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
23
100
2.35
3.47
12.6
3.4
mmol/l
2.3
2.7
0.25
18
72
(3018095) Leukocytes [#/volume] in Urine
212
1700
1.39
3.46
5.1
3.6
e6/l
191.1
100.5
0.55
172
1209
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
57
348
1.71
3.36
2.1
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
185
1460
1.39
3.30
4.8
4.0
ph
7.4
7.4
0.03
47
263
(3007853) Bacteria identified in Skin by Aerobe culture
85
577
1.55
3.29
2.1
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
79
2.45
3.17
3.7
3.1
e9/l
4.9
4.6
0.22
19
79
(3035350) Ketones [Presence] in Urine by Test strip
273
2313
1.34
3.04
5.1
3.7
estimate
0.0
0.0
0.00
58
433
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
412
3717
1.37
2.99
10.9
7.6
u/l
76.5
78.4
0.52
399
3480
(4306422)
16
63
2.58
2.98
1.3
1.3
—
—
—
0
0
(4034850)
29
149
2.00
2.95
8.9
11.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
82
2.36
2.94
4.0
3.4
%
61.5
58.1
0.56
19
82
(3013826) Glucose [Moles/volume] in Serum or Plasma
325
2835
1.33
2.92
7.2
4.7
mmol/l
6.8
6.7
0.18
313
2660
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
230
1914
1.33
2.84
3.0
2.3
nmol/l
76.0
77.0
0.21
218
1703
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
59
2.58
2.80
1.2
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
5
6
8.39
2.75
1.0
1.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
87
621
1.47
2.67
10.1
5.7
mmol/l
1.0
1.0
0.19
82
575
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
43
2.83
2.66
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
271
2328
1.31
2.61
6.4
5.0
estimate
0.0
0.0
0.00
58
429
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
149
1.92
2.60
1.3
1.7
iu/ml
0.1
0.1
—
8
32
(3026782) Osmolality of Urine
124
950
1.39
2.58
3.3
2.8
mosm/kgh2o
526.1
556.0
0.91
110
811
(3032080) INR in Blood by Coagulation assay
236
1992
1.31
2.58
14.1
9.4
inr
1.4
1.2
0.95
82
562
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
180
1463
1.33
2.57
3.0
2.1
u/l
213.3
212.1
0.01
166
1381
(3009871) Measles virus Ab [Titer] in Serum
6
11
5.50
2.55
1.7
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
61
408
1.55
2.54
2.8
3.3
g/l
67.6
66.6
0.35
56
373
(3009261) Glucose [Presence] in Urine by Test strip
273
2354
1.30
2.54
5.1
3.7
estimate
0.0
0.0
0.50
57
415
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
151
1.90
2.51
4.0
3.2
u/ml
0.3
0.3
1.12
20
83
(3014576) Chloride [Moles/volume] in Serum or Plasma
86
620
1.45
2.51
8.8
6.8
mmol/l
104.0
104.1
0.08
81
603
(3023183) Ammonium ion [Moles/volume] in Plasma
22
109
2.06
2.49
2.7
3.2
umol/l
36.2
35.5
0.05
16
93
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
21
3.85
2.47
1.6
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
21
3.85
2.47
1.6
2.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
21
3.85
2.47
1.6
2.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
6
12
5.04
2.40
3.0
7.2
mmol/l
23.8
26.9
—
6
12
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
8
6.29
2.37
1.0
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
243
2083
1.29
2.30
15.0
9.4
e9/l
0.0
0.0
0.58
218
1725
(3015377) Calcium [Moles/volume] in Serum or Plasma
194
1616
1.30
2.29
4.7
3.4
mmol/l
2.3
2.4
0.17
180
1417
(4015189)
6
13
4.65
2.27
2.5
2.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
13
4.65
2.27
2.3
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
157
1273
1.32
2.25
4.6
2.7
umol/l
353.7
7698.4
5.64
141
1095
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
114
1.97
2.23
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
135
1072
1.34
2.23
2.0
1.7
mg/l
1.1
1.3
0.32
110
839
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
9
5.59
2.21
1.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
9
5.59
2.21
1.0
2.9
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
54
2.44
2.21
3.5
4.1
%
64.1
54.6
—
7
40
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
187
1560
1.29
2.16
4.7
3.2
u/l
28.9
31.6
1.19
182
1488
(44813793)
9
30
3.03
2.15
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
134
1069
1.33
2.14
5.1
3.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
55
2.39
2.13
1.1
1.0
u/ml
0.3
8.3
—
5
28
(40767503) Oxygen content in Capillary blood by calculation
19
95
2.03
2.13
3.7
2.3
%
18.0
16.0
0.74
12
43
(46235355) HIV 1 and 2 tests - Meaningful Use set
96
728
1.38
2.12
1.8
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
26
146
1.82
2.10
1.4
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
50
2.43
2.03
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
63
2.25
2.02
1.3
1.3
u/ml
1.4
1.8
—
5
17
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
64
2.22
1.96
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
11
4.57
1.94
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
196
1.67
1.94
2.3
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
2.1
—
—
—
0
0
(4198724)
6
16
3.78
1.94
3.8
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
156
1288
1.29
1.93
4.3
3.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
22
3.21
1.88
1.1
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
22
3.21
1.88
1.6
2.1
%
100.3
94.5
—
7
22
(3037121) Protein [Mass/volume] in Urine
28
167
1.71
1.87
5.6
3.5
g/l
0.2
0.3
0.15
15
68
(3031040) Bacteria [#/volume] in Urine by Automated count
345
3133
1.25
1.87
6.1
4.4
e6/l
51.7
1388.9
1.00
14
54
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
17
3.55
1.84
1.0
3.2
u/l
212.5
211.8
—
6
17
(3000991) Gas panel - Venous blood
57
405
1.45
1.83
9.1
8.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
30
2.69
1.73
1.1
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
48
334
1.48
1.72
2.2
2.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
48
2.32
1.71
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
48
2.32
1.71
3.8
2.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
147
1224
1.27
1.69
2.5
2.1
mg/l
3.2
3.1
0.20
136
1049
(3030467) Casts [#/volume] in Urine by Automated count
159
1337
1.26
1.68
4.3
3.0
e6/l
0.2
0.5
2.51
134
998
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
388
0.60
1.66
1.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
49
2.27
1.64
1.5
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
49
2.27
1.64
1.5
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
49
2.27
1.64
1.5
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
152
1280
1.25
1.58
4.4
3.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
20
114
1.78
1.58
2.7
4.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
44
2.29
1.54
1.8
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
204
0.48
1.52
1.5
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
21
2.88
1.51
1.7
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
16
3.14
1.44
1.0
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
665
1.31
1.43
2.8
2.4
%
20.6
22.4
0.63
68
579
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
71
550
1.33
1.41
4.4
4.3
u/l
265.0
247.5
0.52
64
524
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
74
1.91
1.40
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
43
307
1.43
1.39
3.7
2.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
41
2.21
1.37
1.1
1.1
—
68.0
—
0
5
(3044889) 12 lead EKG panel
363
3373
1.20
1.36
5.0
4.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
68
1.93
1.34
1.3
1.3
u/ml
8.2
4.1
—
6
29
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
18
2.79
1.28
2.2
1.2
ug/l
9.5
8.9
—
5
18
(3035933) Granulocytes/100 leukocytes in Blood
5
18
2.79
1.28
1.4
1.2
—
—
—
0
0
(3036489) Thrombin time
26
170
1.55
1.28
2.5
2.3
s
20.2
21.6
1.23
21
154
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
24
154
1.58
1.28
2.5
4.1
mg/l
25.2
32.7
0.90
16
123
(3034860) Kappa light chains.free [Mass/volume] in Serum
24
154
1.58
1.28
2.5
4.1
mg/l
34.0
95.4
0.83
16
123
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
599
0.73
1.23
4.7
4.7
%
31.0
32.0
0.25
35
395
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
124
1.63
1.22
1.2
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
78
626
1.28
1.22
29.2
24.3
inr
1.6
1.2
0.82
11
81
(3026008) Bacteria identified in Urine by Culture
167
1460
1.20
1.20
3.6
3.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
26
2.32
1.19
16.5
16.1
nmol/l
1075.8
1715.9
—
6
26
(3024263) Appearance of Synovial fluid
6
26
2.32
1.19
1.3
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
350
3265
1.18
1.17
5.7
4.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
137
1179
1.21
1.16
10.7
6.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
95
1.70
1.15
2.2
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
73
586
1.28
1.14
5.5
2.7
%
1.8
1.8
0.17
68
535
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
30
2.35
1.12
7.0
3.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
32
226
1.44
1.12
1.4
2.2
g/l
1.7
1.5
0.58
24
201
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
244
2216
1.17
1.12
5.6
4.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
31
2.27
1.10
1.4
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
232
2101
1.17
1.10
7.6
4.7
g/l
34.6
35.6
1.76
225
1958
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
5
21
2.39
1.09
1.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
428
4472
0.84
1.09
19.8
13.5
ml/min/173m2
77.6
79.6
0.93
355
3704
(40768797) Stomach Pathology biopsy report
80
655
1.26
1.08
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
138
1.54
1.04
1.3
1.3
—
—
—
0
0
(4268621)
9
46
1.97
1.04
2.4
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
34
2.07
1.03
3.6
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
47
1.93
1.02
2.2
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
47
1.93
1.02
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
377
3560
1.17
1.01
4.1
3.9
pmol/l
14.9
14.9
0.12
357
3211
(40761536) Microorganisms panel - Urine sediment
50
390
1.31
0.99
5.0
3.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
61
1.82
0.99
4.0
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
23
2.18
0.98
2.6
2.4
u/ml
526.4
781.1
—
5
23
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
258
0.65
0.97
1.6
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
162
1440
1.17
0.95
3.6
3.3
mg/l
1618.2
244.3
1.28
120
927
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
62
1.79
0.94
6.2
5.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
78
1.68
0.92
1.2
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
28
2.15
0.91
1.0
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
108
931
1.20
0.91
1.9
1.7
nmol/l
1161.8
1186.7
0.11
95
709
(3017569) Oxygen content in Arterial blood
6
29
2.08
0.89
1.3
3.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
119
1.53
0.89
1.3
1.6
e6/l
11465.0
15839.1
0.28
13
92
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
42
1.92
0.89
4.9
2.0
%
14.2
13.2
—
8
42
(3023410) Appearance of Cerebral spinal fluid
8
42
1.92
0.89
3.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
178
1.42
0.87
2.2
1.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
30
222
1.37
0.85
1.1
1.1
titre
—
96.6
—
0
7
(3025941) Bacteria identified in Stool by Culture
36
275
1.33
0.84
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
409
0.74
0.84
1.4
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
11
65
1.71
0.83
1.3
1.2
—
8.0
—
0
5
(3010144) Erythrocytes [#/volume] in Synovial fluid
8
46
1.75
0.82
1.4
1.3
e6/l
8717.1
209953.8
—
8
34
(3017704) Immunofixation for Urine
6
32
1.88
0.82
1.0
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
164
0.60
0.81
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
168
1517
1.15
0.80
3.7
3.1
mmol/l
7.7
7.6
0.17
151
1261
(3019550) Sodium [Moles/volume] in Serum or Plasma
503
4895
1.20
0.80
24.9
17.0
mmol/l
139.7
139.7
0.03
493
4774
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
489
4748
1.19
0.79
23.7
14.5
mg/l
20.4
23.9
2.10
435
3799
(3039443) Prostate specific Ag panel - Serum or Plasma
5
97
0.51
0.78
1.6
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
454
1.23
0.73
4.7
3.6
mmol/l
1.2
2.0
0.72
50
364
(3032773) Endomysium IgG Ab [Titer] in Serum
7
39
1.80
0.72
1.0
1.1
titre
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
110
0.54
0.72
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
354
0.75
0.72
1.6
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
53
437
1.23
0.71
3.9
2.9
e9/l
70.8
72.4
0.12
43
340
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
57
1.59
0.71
1.1
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
57
1.59
0.71
1.2
1.2
nmol/l
0.6
0.5
—
9
50
(3044927) Protein electrophoresis panel - Urine
9
58
1.56
0.70
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
503
4910
1.18
0.68
25.0
17.2
mmol/l
4.0
4.0
2.08
493
4783
(3019230) Fractional oxyhemoglobin in Venous blood
5
93
0.53
0.67
2.6
1.7
%
75.2
59.9
—
5
93
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
43
1.64
0.67
1.4
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
145
1.39
0.66
1.7
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
22
293
0.74
0.66
1.5
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
119
1324
0.87
0.65
1.8
1.7
mmol/l
1.4
1.4
0.31
106
1103
(3021447) Carbon dioxide [Partial pressure] in Venous blood
55
461
1.21
0.65
4.7
3.5
kpa
5.7
5.8
0.21
55
448
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
127
0.62
0.64
1.5
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
87
1.51
0.63
2.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
93
820
1.16
0.62
3.4
2.7
e6/l
0.8
1.2
1.45
64
464
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
49
1.64
0.62
2.0
2.6
nmol/l
5.3
6.6
—
8
49
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
30
1.67
0.61
1.2
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
51
1.58
0.60
1.1
1.2
nmol/l
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
20
0.00
0.60
0.0
1.6
—
98609.9
—
0
11
(3051593) INR in Capillary blood by Coagulation assay
0
21
0.00
0.60
0.0
13.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
52
1.55
0.59
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
430
4427
0.89
0.58
6.3
5.9
mmol/mol
42.1
40.2
1.15
408
4115
(3002256) Pathology report gross observation
52
611
0.84
0.57
1.3
1.3
—
—
—
0
0
(3013512) EKG study
155
1424
1.12
0.57
4.3
4.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
267
2814
0.91
0.56
2.9
2.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
37
304
1.23
0.54
3.1
2.9
e9/l
4.4
4.0
0.44
29
234
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
61
1.48
0.54
1.2
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
305
1.23
0.53
2.0
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
145
1335
1.11
0.52
4.9
4.4
%
21.4
21.2
0.06
81
625
(3022145) Colonoscopy Study observation
46
538
0.84
0.50
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
212
0.75
0.49
1.1
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
119
1.35
0.48
1.1
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
93
1.41
0.48
1.8
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
102
1.38
0.47
1.1
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
111
1.36
0.47
1.5
1.2
mg/l
384.1
457.5
0.87
15
103
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
105
955
1.12
0.47
4.5
3.8
ng/l
1085.4
268.2
0.69
86
745
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
43
501
0.85
0.45
1.5
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
59
519
1.15
0.44
1.7
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
78
1.42
0.43
1.3
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
113
1.34
0.43
1.4
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
56
1.43
0.42
1.3
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
87
1.39
0.42
1.2
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
87
1.39
0.42
4.5
2.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
186
1970
0.92
0.42
2.0
2.0
pmol/l
91.2
95.3
0.65
105
1027
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
28.6
—
0
10
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
100
915
1.11
0.41
3.1
3.0
mmol/l
2.5
2.5
0.93
91
804
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
4.6
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
16
0.00
0.41
0.0
1.2
—
308.7
—
0
10
(3036071) Salmonella sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
169
1.25
0.39
3.4
2.9
g/l
3.3
3.1
0.29
13
137
(3021788) Differential panel - Synovial fluid
11
80
1.38
0.38
1.3
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
67
1.35
0.38
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
470
4613
1.10
0.37
4.9
4.6
mmol/l
5.9
6.0
1.80
443
4200
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
116
1.30
0.37
1.2
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
85
777
1.11
0.36
3.6
2.8
e6/l
2.0
2.0
0.02
55
422
(3045424) Erythrocytes [Presence] in Urine
5
77
0.65
0.36
1.8
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
43
1.40
0.35
3.8
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
181
1.22
0.35
3.3
2.8
g/l
3.5
3.7
0.26
13
135
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
181
1.22
0.35
3.3
2.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
181
1.22
0.35
3.3
2.8
g/l
8.1
7.4
0.67
13
142
(3001122) Ferritin [Mass/volume] in Serum or Plasma
210
2004
1.07
0.34
3.3
2.7
ug/l
152.2
135.8
0.45
202
1830
(3023511) Choriogonadotropin [Units/volume] in Urine
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
66
599
1.11
0.33
8.3
7.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
494
1.13
0.32
3.7
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
160
1517
1.08
0.31
4.4
4.0
mg/mmol
11.7
9.8
0.21
118
960
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
320
3109
1.07
0.30
3.7
3.1
u/l
48.5
49.7
0.12
309
2909
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
130
0.77
0.29
1.2
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
17
139
1.23
0.29
1.6
1.6
nmol/l
40.5
42.0
0.11
17
131
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
364
0.87
0.28
1.8
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
168
1.20
0.27
2.3
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
181
1887
0.94
0.26
2.1
2.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
67
1.20
0.26
8.6
5.0
umol/l
374.3
363.0
—
8
58
(3003740) Influenza virus B Ag [Presence] in Specimen
8
67
1.20
0.26
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
79
734
1.09
0.26
1.5
1.4
—
—
—
0
0
(4094501)
16
132
1.22
0.26
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
202
0.84
0.25
2.4
2.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
137
0.80
0.24
6.3
2.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
133
1.21
0.24
2.1
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
36
322
1.13
0.24
1.7
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
172
1652
1.06
0.23
5.4
5.0
ug/l
2.9
2.7
0.13
159
1483
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
16
134
1.20
0.23
9.1
3.0
mg/l
1.7
1.6
0.13
16
123
(3011648) Oxygen content in Venous blood
5
39
1.28
0.23
2.4
1.8
%
14.8
10.6
—
5
39
(1761868) Lipid panel - Serum or Plasma
160
1666
0.95
0.22
2.8
2.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
43
391
1.11
0.22
3.6
2.7
kpa
4.2
4.4
0.21
43
376
(40761511) CBC panel - Blood by Automated count
500
4949
1.07
0.21
19.6
13.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
102
0.78
0.21
3.4
2.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
43
1.16
0.21
1.6
1.1
nmol/l
1.0
1.7
—
5
37
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.0
—
16.6
—
0
9
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
108
1.21
0.20
3.5
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
393
3991
0.95
0.20
29.1
19.0
g/l
331.3
332.5
1.49
393
3967
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
50
1.20
0.19
1.3
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
51
1.18
0.19
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
164
0.85
0.18
1.4
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
58
1.21
0.18
2.0
2.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
166
1.15
0.18
3.1
2.9
g/l
9.8
10.4
0.17
14
147
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
11
91
1.21
0.17
1.5
3.8
u/ml
617.2
493.4
0.08
11
86
(3045142) Bone marrow Pathology biopsy report
7
62
1.13
0.17
2.6
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
31
282
1.10
0.17
1.1
1.2
iu/ml
49.8
141.1
2.25
15
114
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
68
0.73
0.17
2.8
2.2
u/ml
4.0
63.9
—
5
63
(3011288) Drugs identified in Urine by Screen method
7
86
0.81
0.14
6.3
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
35
324
1.09
0.14
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
139
0.86
0.14
1.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
539
1.06
0.14
2.1
1.8
%
1.6
1.5
0.20
51
476
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
21
232
0.90
0.13
3.9
3.0
u/ml
37.7
60.1
0.51
21
222
(3027944) Amphetamines [Presence] in Urine
16
143
1.12
0.11
3.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
144
1.11
0.10
3.1
1.3
—
—
—
0
0
(4035726)
45
427
1.06
0.10
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
218
0.91
0.10
1.5
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
18
197
0.91
0.10
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
46
1.09
0.09
2.0
3.0
u/ml
24.0
51.2
—
5
46
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
46
1.09
0.09
2.2
2.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
46
1.09
0.09
2.6
2.8
—
—
—
0
0
(4146454)
5
48
1.04
0.09
3.6
2.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
26
243
1.07
0.09
2.5
2.3
%
0.6
0.7
0.33
26
235
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
247
0.93
0.09
1.5
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
165
1.09
0.09
1.3
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
6
56
1.07
0.08
2.2
1.2
mu/l
61.1
43.0
—
6
50
(40768806) Pleura Pathology biopsy report
5
60
0.83
0.08
2.2
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
63
0.79
0.08
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
38
399
0.95
0.08
1.9
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
67
1.05
0.08
2.3
2.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
166
1.09
0.08
1.3
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
74
1.08
0.07
1.3
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
434
4313
1.02
0.07
4.9
4.7
mu/l
2.0
2.2
0.46
410
3915
(3010813) Leukocytes [#/volume] in Blood
524
5260
0.96
0.07
31.8
21.5
e9/l
7.1
6.7
3.11
519
5118
(3000963) Hemoglobin [Mass/volume] in Blood
524
5260
0.96
0.07
31.9
21.6
g/l
136.0
135.5
0.28
519
5179
(3044941) Cell count panel - Synovial fluid
8
76
1.05
0.07
1.0
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
63
610
1.04
0.07
1.6
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
85
1.06
0.07
1.7
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
524
5259
0.96
0.07
31.7
21.4
e12/l
4.6
4.5
2.49
518
5119
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
59
571
1.04
0.07
2.4
2.4
umol/l
8.1
8.6
0.08
50
500
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
88
1.02
0.07
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
128
1.10
0.06
1.4
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
97
992
0.97
0.06
1.3
1.2
u/ml
0.7
1.7
1.39
28
268
(3048689) Calprotectin [Mass/mass] in Stool
52
538
0.96
0.06
1.7
2.2
ug/g
89.7
142.8
1.80
44
434
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
335
1.05
0.06
1.4
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
472
4699
1.02
0.06
4.6
4.5
mmol/l
4.6
4.6
0.03
452
4341
(42529406) Shigella sp [Presence] in Stool by Culture
18
168
1.07
0.06
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
478
4799
0.98
0.05
5.1
5.0
mmol/l
2.8
2.7
0.23
454
4402
(3019225) pH of Specimen
45
465
0.97
0.05
6.6
4.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
507
5056
1.02
0.04
14.4
10.6
u/l
26.4
26.2
0.08
496
4879
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
466
4674
0.98
0.03
4.6
4.5
mmol/l
1.4
1.5
1.54
444
4287
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
54
529
1.02
0.03
3.0
4.3
ug/l
20.7
34.6
0.31
49
447
(1761482) Bacteria [#/volume] in Urine by Culture
13
138
0.94
0.02
3.4
5.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
394
3951
0.99
0.02
26.4
17.7
%
13.9
13.7
2.05
388
3872
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
95
959
0.99
0.01
3.1
3.0
ug/l
0.8
0.8
0.10
74
637
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
592
1.02
0.01
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
94
1.06
0.01
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
94
1.06
0.01
1.6
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
453
4523
1.01
0.00
4.2
4.0
mmol/l
1.3
1.3
0.89
430
4132
(3016879) Cocaine [Presence] in Urine
14
134
1.05
0.00
3.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
196
0.97
0.00
2.3
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
125
1256
0.99
0.00
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
145
1.04
0.00
3.3
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
145
1.04
0.00
3.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
155
0.97
0.00
1.9
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
124
0.97
0.00
1.8
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
113
0.97
0.00
3.5
2.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
256
1.02
0.00
3.0
2.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
242
0.99
0.00
3.5
4.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
151
1513
1.00
0.00
3.4
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
115
1149
1.00
0.00
3.3
2.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
52
0.96
0.00
1.6
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
71
0.99
0.00
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
69
1.01
0.00
1.3
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
86
0.93
0.00
1.3
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
59
0.85
0.00
1.4
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
71
0.99
0.00
1.3
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
61
0.98
0.00
1.3
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
69
1.01
0.00
1.3
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
96
0.94
0.00
1.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
71
0.99
0.00
1.3
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
1.9
—
9104.5
—
0
8
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
84
0.95
0.00
3.7
1.2
u/l
216.1
41.2
—
8
73
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
71
0.99
0.00
1.3
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
70
1.00
0.00
1.3
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
69
1.01
0.00
1.3
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
121
1210
1.00
0.00
1.5
1.5
nmol/l
17.6
21.0
1.74
115
1024
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
58
0.86
0.00
1.4
1.5
ug/l
22.4
16.7
—
5
58
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
70
1.00
0.00
1.3
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
70
1.00
0.00
1.3
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
59
0.85
0.00
1.4
1.3
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_HYPERSPNEUMONI and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_HYPERSPNEUMONI | 1.979 [1.7, 2.31] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.224 |
During the follow-up period (1.1.1998 — 31.12.2019), 288 out of 1173 females with J10_HYPERSPNEUMONI died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_HYPERSPNEUMONI | 1.516 [1.31, 1.76] | < 0.001 |
| Birth year | 0.985 [0.97, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 358 out of 1282 males with J10_HYPERSPNEUMONI died.
Mortality risk
Mortality risk for people of age
years, who have J10_HYPERSPNEUMONI.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.223% | 0.299% |
| 5 | 1.17% | 1.727% |
| 10 | 2.856% | 4.114% |
| 15 | 5.534% | 7.983% |
| 20 | 9.455% | 13.086% |
Relationships between endpoints
↥Index endpoint: J10_HYPERSPNEUMONI – Hypersensitivity pneumonitis due to organic dust
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data